Guardant Health
GH
#1003
Rank
S$30.51 B
Marketcap
S$227.39
Share price
1.75%
Change (1 day)
180.81%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -S$0.59 Billion

According to Guardant Health 's latest financial reports the company's current earnings are S$1.18 Billion. In 2025 the company made an earning of -S$0.54 Billion, an increase over its 2024 earnings that were of -S$0.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.59 Billion9.62%
2025 -S$0.54 Billion-4.03%
2024 -S$0.56 Billion-9.12%
2023 -S$0.62 Billion-26.73%
2022 -S$0.84 Billion69.96%
2021 -S$0.5 Billion56.35%
2020 -S$0.32 Billion252.69%
2019 -S$89.17 Million-17.22%
2018 -S$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-S$11.46 Million-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-S$0.33 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA